Adamas Pharmaceuticals
ADMS
#7320
Rank
A$0.60 B
Marketcap
$13.27
Share price
0.00%
Change (1 day)
17,289.48%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -A$51.16 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are A$88.18 Million. In 2020 the company made an earning of -A$70.82 Million, an increase over its 2019 earnings that were of -A$0.15 Billion.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$51.16 Million-27.77%
2020-A$70.82 Million-51.34%
2019-A$0.15 Billion-19.45%
2018-A$0.19 Billion28.96%
2017-A$0.15 Billion42.3%
2016-A$98.46 Million6.18%
2015-A$92.73 Million-410.24%
2014A$29.88 M-67.53%
2013A$92.04 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.35 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.11 B-287.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.61 B-18,731.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.73 B-10,897.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$24.17 B-38,861.03%๐Ÿ‡บ๐Ÿ‡ธ USA